title: Should anticoagulation therapy be withheld in patients with active cancer after 6 months of low-molecular weight heparin?
authors: University Hospital Morales Meseguer, Murcia, Spain.
authors: Edgar Gerardo
authors: EG
authors: Urrego
authors: University Hospital Morales Meseguer, Murcia, Spain.
authors: Alberto
authors: A
authors: Carmona-Bayonas
authors: University Hospital Morales Meseguer, Murcia, Spain.
authors: Enrique
authors: E
authors: González-Billalabeitia
authors: University Hospital Morales Meseguer, Murcia, Spain frayala@um.es.
authors: Francisco
authors: F
authors: Ayala de la Peña
mesh_terms: D005260:Female; D006495:Heparin, Low-Molecular-Weight / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D009369:Neoplasms / Q000150:complications*; D054556:Venous Thromboembolism / Q000188:drug therapy*; D020246:Venous Thrombosis / Q000188:drug therapy*
chemical_list: D006495:Heparin, Low-Molecular-Weight